Advanced BioScience Laboratories, Inc. (ABL) has opened its new research and manufacturing facility following the expansion of its vaccine and biotherapeutic product development capabilities at its new headquarters in Rockville, MD. The company has invested more than $12 million in the facility expansion, which will serve as headquarters for ABL’s administration, lab services, and cGMP manufacturing, with room for future expansion. Dr. Thomas VanCott, president and chief executive officer of AB...